2026 Q1 -tulosraportti
Vain PDF
89 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. | 4 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 26.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·1 päivä sittenThere is indeed high trading volume it is being pushed down on and low short 0.22 % so it's not them who are pushing it down, I think someone knows something, surely something must soon come out about the 2 big collaboration agreements they have and the result of what they are attempting they are working on?
You are writing low short. If there has been short selling today, it won't be visible until Monday after approximately 12:00.
·2 päivää sitten · MuokattuCrazy enough - even I hadn't thought that would happen. Now Saniona fell out of my range - downwards!! - at 12-15, which I have had as fair value since October 2025. I'm having a bit of difficulty seeing what's causing it. Personally, I myself bought a bit more than planned, as I expect an autumn with a couple of milestones, which I thought would make the Saniona fanatics go crazy again, and push it up to 25-30 (where I would then sell them) - only to fall back to 18-20 again. - progress in partner projects = milestone payments - 1-2 own projects start of clinical phase (I) - maybe an approval in Mexico - a new agreement on one of own projects. There's no doubt that they don't have nearly enough money in the bank for all that they want to do - and as long as they haven't secured a good agreement on one of their 3 internal projects, it might be the uncertainty about a huge emission in 2027/2028 that is controlling the price. Apparently it's not the short sellers, it seems - so it must be some of the larger shareholders who are dumping more than the small ones can absorb.If ChatGPT has a handle on it :-) - then it's completely unproblematic. It should be in connection with everything being moved into a French company, and Saniona's ownership stake also seems to be moving with it. So there seems to be a completely normal solvent liquidation in connection with a restructuring of operations - possibly to get a more international setup and attract new investors. Haven't gone deeper into it than a quick ChatGPT query - so you might want to investigate yourself.: ----------------------------- CHATGPT: There is even a very strong clue in the French documents: Upon the establishment of the French company, Saniona's ownership stake in the Danish company was valued at €1 mio., and Saniona in return received 178.750 shares in the new French company as well as up to 204.286 warrants/BSA's. So my preliminary conclusion is: Cephagenix is not being compulsorily dissolved as a biotech-case. It is the old Danish legal entity, Cephagenix ApS, that is undergoing compulsory liquidation, after the Cephagenix structure has been reorganized around a new French company.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
89 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenThere is indeed high trading volume it is being pushed down on and low short 0.22 % so it's not them who are pushing it down, I think someone knows something, surely something must soon come out about the 2 big collaboration agreements they have and the result of what they are attempting they are working on?You are writing low short. If there has been short selling today, it won't be visible until Monday after approximately 12:00.
- ·2 päivää sitten · MuokattuCrazy enough - even I hadn't thought that would happen. Now Saniona fell out of my range - downwards!! - at 12-15, which I have had as fair value since October 2025. I'm having a bit of difficulty seeing what's causing it. Personally, I myself bought a bit more than planned, as I expect an autumn with a couple of milestones, which I thought would make the Saniona fanatics go crazy again, and push it up to 25-30 (where I would then sell them) - only to fall back to 18-20 again. - progress in partner projects = milestone payments - 1-2 own projects start of clinical phase (I) - maybe an approval in Mexico - a new agreement on one of own projects. There's no doubt that they don't have nearly enough money in the bank for all that they want to do - and as long as they haven't secured a good agreement on one of their 3 internal projects, it might be the uncertainty about a huge emission in 2027/2028 that is controlling the price. Apparently it's not the short sellers, it seems - so it must be some of the larger shareholders who are dumping more than the small ones can absorb.If ChatGPT has a handle on it :-) - then it's completely unproblematic. It should be in connection with everything being moved into a French company, and Saniona's ownership stake also seems to be moving with it. So there seems to be a completely normal solvent liquidation in connection with a restructuring of operations - possibly to get a more international setup and attract new investors. Haven't gone deeper into it than a quick ChatGPT query - so you might want to investigate yourself.: ----------------------------- CHATGPT: There is even a very strong clue in the French documents: Upon the establishment of the French company, Saniona's ownership stake in the Danish company was valued at €1 mio., and Saniona in return received 178.750 shares in the new French company as well as up to 204.286 warrants/BSA's. So my preliminary conclusion is: Cephagenix is not being compulsorily dissolved as a biotech-case. It is the old Danish legal entity, Cephagenix ApS, that is undergoing compulsory liquidation, after the Cephagenix structure has been reorganized around a new French company.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. | 4 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 26.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
89 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. | 4 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 26.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenThere is indeed high trading volume it is being pushed down on and low short 0.22 % so it's not them who are pushing it down, I think someone knows something, surely something must soon come out about the 2 big collaboration agreements they have and the result of what they are attempting they are working on?You are writing low short. If there has been short selling today, it won't be visible until Monday after approximately 12:00.
- ·2 päivää sitten · MuokattuCrazy enough - even I hadn't thought that would happen. Now Saniona fell out of my range - downwards!! - at 12-15, which I have had as fair value since October 2025. I'm having a bit of difficulty seeing what's causing it. Personally, I myself bought a bit more than planned, as I expect an autumn with a couple of milestones, which I thought would make the Saniona fanatics go crazy again, and push it up to 25-30 (where I would then sell them) - only to fall back to 18-20 again. - progress in partner projects = milestone payments - 1-2 own projects start of clinical phase (I) - maybe an approval in Mexico - a new agreement on one of own projects. There's no doubt that they don't have nearly enough money in the bank for all that they want to do - and as long as they haven't secured a good agreement on one of their 3 internal projects, it might be the uncertainty about a huge emission in 2027/2028 that is controlling the price. Apparently it's not the short sellers, it seems - so it must be some of the larger shareholders who are dumping more than the small ones can absorb.If ChatGPT has a handle on it :-) - then it's completely unproblematic. It should be in connection with everything being moved into a French company, and Saniona's ownership stake also seems to be moving with it. So there seems to be a completely normal solvent liquidation in connection with a restructuring of operations - possibly to get a more international setup and attract new investors. Haven't gone deeper into it than a quick ChatGPT query - so you might want to investigate yourself.: ----------------------------- CHATGPT: There is even a very strong clue in the French documents: Upon the establishment of the French company, Saniona's ownership stake in the Danish company was valued at €1 mio., and Saniona in return received 178.750 shares in the new French company as well as up to 204.286 warrants/BSA's. So my preliminary conclusion is: Cephagenix is not being compulsorily dissolved as a biotech-case. It is the old Danish legal entity, Cephagenix ApS, that is undergoing compulsory liquidation, after the Cephagenix structure has been reorganized around a new French company.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt